NEUROLMED Co.
Latest round
- Seed
Last raised
- Feb 2022
Total raised
- Undisclosed
Investors
- 4
About NEUROLMED Co.
, Ltd. is a biotechnology company that offers drugs designed to treat patients with central nervous system diseases. The company was founded by its CEO, Kang-Hoon Je. NEUROLMED develops and offers drugs from biomolecules and natural products for chronic degenerative cerebral disorders, like stroke, Parkinson's disease, and Alzheimer's disease. The firm’s pipeline drug includes NRM-331, a small-molecule drug for cerebral ischemic reperfusion injury; NRM-205; NRM-021; and NRM-803. NeurolMed's AI platform uses computer science technology and next-generation semiconductor-based AI technology to solve new challenges in brain science.
Who invested in NEUROLMED Co.
4 investors across 3 rounds
See all investors in NEUROLMED Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NEUROLMED Co.
Who invested in NEUROLMED Co.?
NEUROLMED Co. has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NEUROLMED Co. raised?
NEUROLMED Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did NEUROLMED Co. last raise money?
NEUROLMED Co.'s most recent round on record is a Seed, in Feb 2022.
What does NEUROLMED Co. do?
NEUROLMED Co. is a biotechnology company.
Where is NEUROLMED Co. headquartered?
NEUROLMED Co. is headquartered in Gyeonggi-do, South Korea.
Which VCs invest in companies like NEUROLMED Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at NEUROLMED Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like NEUROLMED Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.